Nucleotide Metabolism (Week 4--Kurdistani) Flashcards
Nucleotide vs. nucleoside
Nucleotide: base + pentose/ribose sugar + phosphate (ex: AMP, GMP, CMP, UMP, dTMP)
Nucleoside: base + pentose/ribose sugar (ex: adenosine, guanosine, cytidine, uridine, deoxythimidine)
What are the 2 types of pentose sugars?
Ribose (in RNA) has 2’ OH
Deoxyribose (in DNA) has 2’ H
What are the 2 types of bases?
Purines: adenine (A), guanine (G)–have 2 rings
Pyrimidines: cytosine (C), uracil (U), thymine (T)–have 1 ring
Note: T only in DNA and U only in RNA
Where does the base attach to the pentose sugar?
Base attaches to 1’ carbon of pentose sugar, on same side of base as 5’ carbon (which eventually picks up phosphate)
Attachment is by beta-glycosidic linkage (enzyme that cleaves linkage is called phosphorylase)
Cellular roles of nucleotides
1) Monomeric units of nucleic acids
2) Energy metabolism: ATP, activated intermediates (UDP-glucose)
3) Regulation of physiological processes: adenosine and coronary blood flow, cAMP/cGMP as signaling molecules, allosteric regulators
4) Coenzyme components: FAD, NAD+, CoA
How do you synthesize nucleotides (purines and pyrimidines)?
1) De novo biosynthesis: from scratch; from AAs, ribose-5-P, CO2, NH3
2) Salvage pathway: recycling from pre-existing nucleotides (cells die and you can use their old nucleotides)
Note: purines do de novo more; pyrimidines do salvage more
Why do we do de novo synthesis?
Don’t get enough nucleotides in diet
How does de novo synthesis of nucleotides occur?
Occurs in most cells, but liver is major site of de novo synthesis
Purines: the purine rings are built onto ribose-5-phosphate
Pyrimidines: the pyrimidine ring is synthesized then attached onto the ribose-5-phosphate
Phosphoribosylpyrophosphate (PRPP) is intermediate in both purine and pyrimidine synthesis
What is PRPP?
Phosphoribosyl-pyrophosphate (PRPP) is an activated ribose sugar that is used to synthesize nucelotides de novo
Ribose 5-phosphate + ATP –> PRPP + AMP
(PRPP synthetase catalyzes reaction; ribose 5-phosphate comes from pentose phosphate pathway, which is a shunt off of glycolysis)
Takes energy to synthesize PRPP (and thus nucleotides)
Steps in de novo biosynthesis of PURINEs
1) Regulated step: Ribose-5-phosphate + ATP –> PRPP + glutamine (via PRPP synthetase); at this step, control enzyme activity via feedback/feedforward to slow/speed process
2) Committed step: PRPP + glutamine –> 5-phosphoribosyl amine + glutamate +PPi (via amidophosphoribosyl transferase); this is point of no return (and often is regulated by final product)
3) 9 more steps then get IMP (inosine monophosphate)
4) IMP converted to GMP (by ATP) or AMP (by GTP)
5) GMP and AMP are phosphorylated, then phosphorylated again or acted on by ribonucleotide reductase (RNR) to make dGDP and dADP
6) Get GTP, ATP, dGTP, or dATP
What are purines degraded to?
Purines (AMP, GMP) degraded to xanthine then to uric acid which is excreted in urine
If uric acids loses H+, turns into urate, which is insoluble and can cause gout if it accumulates enough
Note: food purines are degraded to uric acid by gut epithelium
Gout
Caused by too much uric acid in the blood (hyperuricemia)
Primary gout: inherited; more in males, overactivity of PRPP synthetase; Lesch-Nyhan syndrome is X-linked recessive (get gout AND neurological symptoms)
Secondary gout: medications, too much cell death (chemo), chronic kidney failure
Clinical characteristics: hyperuricemia, arthritis (usually in big toe), kidney malfunction
Pathology: precipitation of sodium urate crystals in joints or other tissues, or in urinary tract (or kidneys); tophi are large visible crystals in joints/soft tissue
Treatment of gout
NSAIDs, corticosteroids, colchicine, allopurinol, avoid alcohol and foods with purines
Colchicine interferes with function of microtubules so inflammatory cells (neutrophils) can’t get to site where crystals formed so can’t cause inflammation
Allopurinol is similar to hypoxanthine (which is a substrate for xanthine oxidase in the process of degrading purines) so it essentially inhibits xanthine oxidase so that xanthine can no longer be turned to uric acid (“suicide inhibitor” because enzyme converts it to oxipurinol (alloxanthine) which does not dissociate and inhibits the enzyme)
Probenecid inhibits uric acid reabsorption at PCT (tx chronic gout)
Sulfinpyrazone Inhibits uric acid reabsorption (tx chronic gout or gouty arthritis)
Pseudogout
Arthritis caused by deposition of calcium pyrophosphate crystals, in knee or wrist
Caused by excessive Ca2+ in blood (overactive parathyroid gland, hemochromatosis, hypothyroidism); incidence increases with age
Adenosine deaminase (ADA)
Enzyme that degrades d-adenosine –> d-inosine that then goes to hypoxanthine (via purine nucleoside phosphorylase) then uric acid
This is how dAMP is degraded; note that AMP is degraded to uric acid differently–using AMP deaminase for AMP –> IMP –> inosine –> hypoxanthine –> uric acid
Severe Combined Immunodeficiency Disorder (SCID)
Severe defects in level and activity of B and T cells causes recurrent infections and failure to thrive
Caused by deficiency in adenosine deaminase (ADA) that causes elevated levels of ATP and thus dATP
dATP is highly toxic because inhibits RNR, so inhibits synthesis of other deoxynucleotides and DNA so cells can’t divide/signal. Lymphoid cells most susceptible to ADA deficiency
Treatment: bone marrow transplant or gene therapy
What hapens when you have deficiency in purine nucleoside phosphorylase (PNP)?
Get increased levels of GTP and dGTP, which also inhibit RNR (like ATP and dATP) and cause toxicity to immune system
Get less severe form of immunodeficiency
Purine salvage pathways to synthesize nucleotides
Adenine and Guanine use different enzymes for the purine salvage pathway:
1) Adenine + PRPP –> AMP + PPi (via adenine phosphoribosyl transferase (APRT))
2) Guanine (or hypoxanthine) + PRPP –> GMP (or IMP) + PPi (via hypoxanthine (guanine) phosphoribosyl transferase (HGPRT))
What exactly is “salvaged” in the purine salvage pathways?
The base–adenine or guanine (so the rings with the nitrogen in them!)
(note that this is different from pyrimidine salvage, which uses nucleosides!)
Lesch-Nyhan Syndrome
Defective HGPRT causes increased uric acid (orange crystals in diaper!)
X-linked so primarily in males
Get neurological defects (dystonia, choreoathetosis, ballismus), behavior problems (aggressive, compulsive self-mutilation)
Mechanism of hyperuricemia: decreased salvage leads to (1) more purine degradation and (2) buildup of PRPP which stimulates committed step in de novo purine synthesis so get more uric acid generation
Treatment: allopurinol to reduce uric acid production, hydration to prevent urate crystal deposition (esp in kidney)
Pyrimidine de novo biosynthesis
Pyrimidine ring synthesized first then attached to ribose (unlike purine, which is built ON ribose)
However, note that it’s not exactly the final pyrimidine ring that is synthesized–it still has a CO2 on there that shouldn’t be, and this ring is called orotate
Orotate attached to PRPP to form UMP
From UMP –> UTP –> CTP
Last pyrimidine we need to synthesize is thymidine: dUTP –>dUMP –> dTMP
6 steps to synthesize UMP
1) NH3 (from AA glutamine) + HCO3- + 2 ATP –> carbamoyl phosphate
2) Carbamoyl phosphate + aspartate –> carbamoyl aspartate
3) Carbamoyl aspartate –> dihydroorotate
4) Dihydroorotate –> orotate
5) Orotate + PRPP –> orotidine monophosphate (OMP)
6) Orotidine monophosphate –> uridine monophosphate (UMP)
In the pyrimidine ring that is formed de novo, where do the N’s and C’s come from?
N1, C4,5,6 come from aspartate
C2, N3 come from carbamoyl phosphate (and furthermore, N3 usually comes from glutamine)